- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in roche
Working To Increase Production Capacity Of Actemra: Roche
India saw a record single-day rise of 3,60,960 coronavirus cases, which pushed the total tally to 1,79,97,267, while the death toll crossed two lakh following 3,293 fresh fatalities.
Read More
Roche Buys GenMark For $1.8 Million To Challenge Test Rivals
The market for such tests in 2019 was $800 million annually, Roche diagnostics head Thomas Schinecker said, citing industry figures, adding it should grow by 20% annually to top $2 billion by 2024.
Read More
Roche Arthritis Drug Reduces COVID-19 Deaths In Trial In Hospitalised Patients
Actemra rose to become Roche's fifth-best-selling drug, at more than $3 billion, with nearly $600 million from COVID-19 treatment.
Read More
Roche Fourth-Quarter Sales Helped By COVID-19 Test Business
Sales were 58.3 billion francs, down 5% from 61.5 billion a year ago as the strong Swiss franc weighed on revenue but 1% higher at constant currency rates.
Read More
Roche Confirms 2020 Outlook As COVID-19 Diagnostics Surge
Sales of diagnostics including tests for the new coronavirus, of which Roche offers several to both detect active and past infections, rose 2% through September to 9.7 billion Swiss francs ($10.6 billion)
Read More
UK's COVID-19 Testing System Hit By Roche Supply Problems
Roche is one of the main suppliers of diagnostic tests to the National Health Service (NHS) Test and Trace programme, which has already suffered setbacks including a technical glitch that delayed the reporting of 15,000 positive results.
Read More
Roche Studies Ocrevus, Experimental Drug In MS As Novartis Moves In
Roche has started a late-stage clinical trial for its molecule fenebrutinib and is doing a clinical trial of higher-dose Ocrevus against relapsing MS and primary progressive MS.
Read More
Roche Receives US Emergency Approval For Coronavirus Vs. Flu Test
With the approaching flu season, this new test is particularly important as SARS-CoV-2 and influenza infections can hardly be differentiated by symptoms alone.
Read More
Roche Bid To Retool Arthritis Drug For COVID-19 Fails
Pharmaceutical companies have been racing to develop treatments against the COVID-19 pandemic that has claimed nearly 660,000 lives and crippled economies.
Read More
Roche Maintains 2020 Outlook As Second-Quarter Sales Tumble On COVID-19 Hit
Second-quarter sales dropped 9.6% to 14.1 billion Swiss francs ($15.20 billion). Factoring out the strong Swiss franc, revenue fell 4%
Read More
EU Secures Potential COVID-19 Drugs From Roche, Germany's Merck
The medicine is also being tested on COVID-19 patients in combination with Gilead's antiviral remdesivir, the only drug so far authorised by the EU for use against COVID-19. Patients are still being recruited
Read More
EU Reaches Deals With Roche, Merck For Supply Of COVID-19 Drugs
The agreements follow requests from EU states in May to acquire the two drugs which are considered potentially useful against COVID-19.
Read More
Rising Swiss Rivalry As Roche And Novartis Target Same Diseases
Roche Chief Executive Severin Schwan is looking beyond cancer drugs to fresh treatment areas, while Novartis CEO Vas Narashiman bulks up in the same territory.
Read More
Roche Confirms 2020 Sales, Profit Outlook As Coronavirus Boosts Test Demand
Group sales in the first-quarter rose 7% to 15.1 billion Swiss francs ($15.57 billion), with drugs business revenue up 7% and diagnostics rising 5% at constant exchange rates.
Read More
Govt Issues Alert To Deter Use Of Roche's Avastin Drug For Eyes
Despite being a cancer drug, Avastin is often used by doctors globally for eye ailments even though it does not have US Food and Drug Administration approval for that purpose
Read More